Items Tagged ‘gbm’

October 22nd, 2015

Optune Approved for Newly Diagnosed Glioblastoma Multiforme

By

The United States Food and Drug Administration has expanded the approval of the Optune device for the treatment of patients with newly diagnosed glioblastoma multiforme. Glioblastoma multiforme (GBM) is an extremely aggressive form of brain cancer. Average survival of patients with GBM is less than 15 months because the cancer tends to be resistant to […]

View full entry

Tags: Brain Cancer, gbm, General Brain Cancer, glioblastoma multiforme, News, Optune device, temozolomide, TTFields


July 13th, 2015

Researchers Recruit Herpes Virus as Part of Brain Cancer Treatment

By

A therapy that uses the herpes virus to make tumors more vulnerable to treatment appears promising in the treatment of glioblastoma multiforme (GBM), a form of brain cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical […]

View full entry

Tags: AdV-Tk, Brain Cancer, clinical trial, gbm, Gene Therapy, General Brain Cancer, gliobastoma multiforme, herpes virus, News, treatment


July 1st, 2015

Rintega® Improves Survival in Patients with Glioblastoma Multiforme

By

The immunotherapy drug Rintega® (rindopepimut) appears to improve survival among patients with relapsed glioblastoma multiforme (GBM) brain cancer. These findings were presented at 2015 Annual Meeting of the American Society of Clinical Oncology (May 29–June 2, Chicago, Illinois) and published in the Journal of Clinical Oncology. Glioblastoma multiforme is one of the most common and […]

View full entry

Tags: avastin, bevacizumab, Brain Cancer, clinical trial, EGFRvIII, gbm, General Brain Cancer, glioblastoma multiforme brain cancer, News, rindopepimut, Rintega


February 3rd, 2015

Danish Study Suggests Contraceptive Use Increases Risk of Brain Cancer

By

The results of a recently published clinical study suggest that taking the birth control pill for at least five years may double the risk of developing a glioblastoma multiforme (GBM), a rare but often fatal from of brain cancer. Glioblastoma multiforme is one of the most common and fatal types of primary brain cancer. It […]

View full entry

Tags: birth control, Brain Cancer, cancer risk, contraceptive, gbm, General Brain Cancer, glioblastoma, glioblastoma multiforme, News


September 19th, 2014

DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial

By

DNAtrix, Inc., experts in oncolytic virus development, today announced that the first patient was treated with the company’s lead product, DNX-2401, a replication competent adenovirus plus gamma interferon in a randomized, multicenter, open-label Phase Ib study for patients with recurrent glioblastoma. “DNAtrix, in collaboration with leading neurosurgeons and neuro-oncologists in the US, is pleased to […]

View full entry

Tags: adenovirus, Brain Cancer, dnx-2401, gamma interferon, gbm, General Brain Cancer, glioblastoma, News, recurrent glioblastoma


June 24th, 2014

Chemotherapy Following Radiation Improves Outcomes in Low Grade Glioblastoma

By

According to results recently presented at the 2014 annual meeting of the American Society of Clinical Onoclogy, patients with low-grade glioblastom multiforme (GBM) benefited from chemotherapy following radiation therapy compared to radiation therapy alone. consisting of procarbazine, CCNU, and vincristine (PCV) administered following radiation therapy improved progression-free survival and overall survival in adults with low-grade […]

View full entry

Tags: Brain Cancer, gbm, General Brain Cancer, glioblastom multiforme, glioblastoma, News